GC | GenomeWeb

GC

NEW YORK (GenomeWeb) – Saying that it does not believe its Chemical and Applied Markets division can achieve "acceptable financial performance" in the next two years, Bruker today said that it plans to sell and/or restructure certain parts of the CAM business, resulting in an expected 200 to 250

NEW YORK (GenomeWeb News) – Agilent Technologies has signed a definitive agreement to buy assets from ABC Instrumentacion Analitica, the two companies announced today.
Financial and other terms were not disclosed.

NEW YORK (GenomeWeb News) – A genome sequencing study in Nature offered hints about genetic strategies organisms may use to maintain species diversity, even in the absence of sexual repr

NEW YORK (GenomeWeb News) – Leco and Danaher business AB Sciex today announced a co-marketing agreement to offer bundled liquid chromatography and gas chromatography, mass spectrometry-based solutions to metabolomics researchers.

Bruker plans for Bruker-Michrom to continue developing Michrom's HPLC and other liquid chromatography assets.

Shimadzu's LC and GC systems sold in the US will come with Phenomenex columns, under the terms of the deal.

Bruker has completed its acquisition of three product lines from Varian, which it expects will "perfectly complement" its portfolio of mass spectrometry products.

The sale of the product lines to Bruker will clear the way for Agilent to complete its $1.5 billion acquisition of Varian, which is now expected by the end of April.

The NCFST will collaborate with Agilent and use Agilent's mass spectrometry, chromatography, and DNA analysis systems.

The sales of certain gas chromatography product lines will satisfy the conditions for clearance of the acquisition in the EU.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.